BR112013028296A2 - métodos para detecção de variantes de sequências de ácido nucléico - Google Patents

métodos para detecção de variantes de sequências de ácido nucléico

Info

Publication number
BR112013028296A2
BR112013028296A2 BR112013028296A BR112013028296A BR112013028296A2 BR 112013028296 A2 BR112013028296 A2 BR 112013028296A2 BR 112013028296 A BR112013028296 A BR 112013028296A BR 112013028296 A BR112013028296 A BR 112013028296A BR 112013028296 A2 BR112013028296 A2 BR 112013028296A2
Authority
BR
Brazil
Prior art keywords
nucleic acid
methods
target region
acid sequence
sequence variants
Prior art date
Application number
BR112013028296A
Other languages
English (en)
Other versions
BR112013028296B1 (pt
Inventor
Lyle Arnold
Original Assignee
Aegea Biotechnologies
Biocept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aegea Biotechnologies, Biocept Inc filed Critical Aegea Biotechnologies
Publication of BR112013028296A2 publication Critical patent/BR112013028296A2/pt
Publication of BR112013028296B1 publication Critical patent/BR112013028296B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/185—Modifications characterised by incorporating bases where the precise position of the bases in the nucleic acid string is important
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/186—Modifications characterised by incorporating a non-extendable or blocking moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/197—Modifications characterised by incorporating a spacer/coupling moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10—Detection mode being characterised by the assay principle
    • C12Q2565/102—Multiple non-interacting labels
    • C12Q2565/1025—Multiple non-interacting labels labels being on the same oligonucleotide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Abstract

resumo patente de invenção: "métodos para detecção de variantes de sequências de ácido nucléico". a presente invenção refere-se a métodos para detecção da presença ou ausência de uma variante de ácido nucléico em uma região alvo. estes métodos incluem amplificação da região alvo com um primer avançado para frente e um primer reverso na presença de um bloqueador de seletor. o bloqueador de seletor inclui uma sequência complementar à região alvo na ausência da variante de ácido nucléico. os métodos incluem adicionalmente detecção de amplificação da região alvo onde amplificação da região alvo indica a presença da variante de ácido nucléico na região alvo. a variante de ácido nucléico pode incluir eliminações, mutações ou inserções.
BR112013028296-7A 2011-05-04 2012-05-04 Métodos para detecção de variantes de sequências de ácido nucléico BR112013028296B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161482576P 2011-05-04 2011-05-04
US61/482,576 2011-05-04
PCT/US2012/036678 WO2012151560A2 (en) 2011-05-04 2012-05-04 Methods for detecting nucleic acid sequence variants

Publications (2)

Publication Number Publication Date
BR112013028296A2 true BR112013028296A2 (pt) 2016-09-06
BR112013028296B1 BR112013028296B1 (pt) 2020-03-24

Family

ID=47108269

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013028296-7A BR112013028296B1 (pt) 2011-05-04 2012-05-04 Métodos para detecção de variantes de sequências de ácido nucléico

Country Status (8)

Country Link
US (4) US9834817B2 (pt)
EP (2) EP3382039B1 (pt)
JP (4) JP6404118B2 (pt)
KR (3) KR102252447B1 (pt)
CN (2) CN103635593B (pt)
AU (3) AU2012250516B2 (pt)
BR (1) BR112013028296B1 (pt)
WO (1) WO2012151560A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102301005A (zh) 2008-12-17 2011-12-28 生命技术公司 用于检测等位基因变体的方法、组合物和试剂盒
EP2411543B1 (en) 2009-03-27 2017-04-19 Life Technologies Corporation Methods, compositions, and kits for detecting allelic variants
KR102252447B1 (ko) * 2011-05-04 2021-05-17 바이오셉트 인코포레이티드 핵산 서열 변이체를 검출하는 방법
WO2014164874A2 (en) * 2013-03-13 2014-10-09 Becton, Dickinson And Company Methods and compositions for modulation of amplification efficiency
WO2014152091A2 (en) * 2013-03-15 2014-09-25 Carnegie Institution Of Washington Methods of genome sequencing and epigenetic analysis
EP2971134B1 (en) 2013-03-15 2023-10-25 Aegea Biotechnologies, Inc. Methods for amplifying fragmented target nucleic acids utilizing an assembler sequence
EP2981623A4 (en) 2013-04-05 2016-11-23 Robert A Akins SYSTEMS AND METHOD FOR THE ASSESSMENT OF MICROBIOMES AND TREATMENTS THEREOF
US9410172B2 (en) 2013-09-16 2016-08-09 General Electric Company Isothermal amplification using oligocation-conjugated primer sequences
KR20160064192A (ko) 2013-10-03 2016-06-07 얀센 바이오테크 인코포레이티드 프로톡신-ii 변이체 및 사용 방법
DK3146080T3 (en) * 2014-05-19 2021-04-12 Univ Rice William M Allele-specific amplification using a composition of overlapping non-allele-specific primer and allele-specific blocker oligonucleotides
HUE047958T2 (hu) 2014-08-07 2020-05-28 Pharmassist Ltd A PIK3CA mutációs állapotának meghatározási módszere a mintában
KR20170134542A (ko) * 2015-04-02 2017-12-06 얀센 바이오테크 인코포레이티드 프로톡신-ii 변이체 및 사용 방법
EP3283627B1 (en) * 2015-04-15 2021-12-01 The General Hospital Corporation Lna-based mutant enrichment next-generation sequencing assays
CN107849606A (zh) 2015-04-20 2018-03-27 尼欧基因组学实验室股份有限公司 提高下一代测序灵敏度的方法
WO2017070281A1 (en) * 2015-10-21 2017-04-27 Admera Health LLC Blocker-based enrichment system and uses thereof
US11414686B2 (en) 2016-05-06 2022-08-16 William Marsh Rice University Stoichiometric nucleic acid purification using randomer capture probe libraries
CN107577921A (zh) * 2017-08-25 2018-01-12 云壹生物技术（大连）有限公司 一种肿瘤靶向基因测序数据解析方法
CN108048531B (zh) * 2017-11-16 2021-06-18 苏州吉玛基因股份有限公司 一种高灵敏度检测稀有突变的超阻滞荧光定量pcr方法
AU2019311015A1 (en) * 2018-07-24 2021-02-18 Salish Bioscience Inc. Methods and composition for targeted genomic analysis
CN109136345A (zh) * 2018-09-21 2019-01-04 北京知光基因科技有限公司 一种扩增并检测低含量基因突变的pcr方法及其应用
US11921049B2 (en) * 2018-11-09 2024-03-05 Shaofeng Ding Pyrophosphorolysis activated fluorescence to measure PAP amplification of nucleic acid
CN110004219A (zh) * 2019-04-19 2019-07-12 格尚微(上海)生物科技有限公司 一种egfr t790m和c797s顺式突变的检测方法
WO2021151395A1 (zh) * 2020-01-30 2021-08-05 上海快灵生物科技有限公司 基于双标记寡核苷酸探针熔解曲线的多重检测靶核苷酸序列的方法及其试剂盒
CN111647650B (zh) * 2020-07-06 2023-06-27 河南赛诺特生物技术有限公司 检测人B-raf基因V600E突变的引物、引物探针组合物及试剂盒

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180338B1 (en) * 1992-08-04 2001-01-30 Beckman Coulter, Inc. Method, reagent and kit for the detection and amplification of nucleic acid sequences
US5767259A (en) * 1994-12-27 1998-06-16 Naxcor Oligonucleotides containing base-free linking groups with photoactivatable side chains
ATE318327T1 (de) * 1996-06-04 2006-03-15 Univ Utah Res Found Fluoreszenz-donor-akzeptor paar
US6399304B1 (en) * 1996-12-20 2002-06-04 Roche Diagnostics Gmbh Sequential activation of one or more enzymatic activities within a thermocycling reaction for synthesizing DNA molecules
US5928869A (en) 1997-05-30 1999-07-27 Becton, Dickinson And Company Detection of nucleic acids by fluorescence quenching
US20030165888A1 (en) * 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
ES2447419T3 (es) * 1999-09-13 2014-03-12 Nugen Technologies, Inc. Composiciones para la amplificación isotérmica lineal de secuencias de polinucleótidos
US6379888B1 (en) 1999-09-27 2002-04-30 Becton, Dickinson And Company Universal probes and methods for detection of nucleic acids
GB9928884D0 (en) * 1999-12-08 2000-02-02 Nmt Group Plc Closure assembly
WO2002061133A2 (en) * 2000-11-09 2002-08-08 Yale University Nucleic acid detection using structured probes
US6479244B1 (en) * 2001-04-23 2002-11-12 Galileo Genomics Method for genotyping microsatellite DNA markers
DE60235491D1 (de) * 2001-11-28 2010-04-08 Bio Rad Laboratories Paralleles scoring von polymorphismen mittels amplifikation und fehlerkorrektur
CA2468754C (en) * 2001-12-08 2011-11-15 Seegene, Inc. Annealing control primer and its uses
JP2004081051A (ja) * 2002-08-23 2004-03-18 Srl Inc ラミブジン耐性ｂ型肝炎ウイルスの測定方法及びそれに用いられる核酸
US8679789B2 (en) 2003-05-01 2014-03-25 Gen-Probe Incorporated Oligonucleotides comprising a molecular switch
JP2006166808A (ja) * 2004-12-16 2006-06-29 Olympus Corp 塩基配列解析用プローブ及び塩基配列解析用固相化担体、並びに塩基配列解析方法
JP2008529528A (ja) * 2005-02-09 2008-08-07 ストラタジーン カリフォルニア ポリヌクレオチドの検出用のキープローブ組成物および方法
WO2006095941A1 (en) * 2005-03-05 2006-09-14 Seegene, Inc. Processes using dual specificity oligonucleotide and dual specificity oligonucleotide
US20100009355A1 (en) 2006-03-14 2010-01-14 Kolodney Michael S Selective amplification of minority mutations using primer blocking high-affinity oligonucleotides
ES2345954T3 (es) * 2006-05-12 2010-10-06 Cepheid Deteccion de la union de recombinacion de adn.
JP5142244B2 (ja) * 2006-10-05 2013-02-13 独立行政法人産業技術総合研究所 新規蛍光標識核酸
GB0703996D0 (en) * 2007-03-01 2007-04-11 Oxitec Ltd Nucleic acid detection
DK2134861T3 (da) * 2007-03-08 2012-07-30 Idaho Technology Fremgangsmåde for smelteanalyse af nukleinsyrer
US8071338B2 (en) * 2007-08-08 2011-12-06 Roche Molecular Systems, Inc. Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity
CN101280338B (zh) * 2007-12-13 2011-08-17 中国人民解放军第三军医大学第一附属医院 一种检测核酸多态性的核酸扩增方法
US20100068711A1 (en) * 2008-07-18 2010-03-18 Xenomics, Inc. Methods of PCR-Based Detection of "Ultra Short" Nucleic Acid Sequences
CN102301005A (zh) 2008-12-17 2011-12-28 生命技术公司 用于检测等位基因变体的方法、组合物和试剂盒
EP2411543B1 (en) * 2009-03-27 2017-04-19 Life Technologies Corporation Methods, compositions, and kits for detecting allelic variants
US8409802B2 (en) * 2009-08-14 2013-04-02 Roche Molecular Systems, Inc. Format of probes to detect nucleic acid differences
WO2011027966A2 (en) * 2009-09-03 2011-03-10 Seegene, Inc. Td probe and its uses
DE102010025496A1 (de) * 2009-10-09 2011-04-21 Universität Duisburg-Essen Verfahren zur Detektion von Genveränderungen, insbesondere Mutationen
CA2819431C (en) * 2010-12-02 2021-09-28 Keygene N.V. Targeted alteration of dna with oligonucleotides.
KR102252447B1 (ko) 2011-05-04 2021-05-17 바이오셉트 인코포레이티드 핵산 서열 변이체를 검출하는 방법

Also Published As

Publication number Publication date
CN108220406B (zh) 2022-09-30
CN108220406A (zh) 2018-06-29
AU2012250516B2 (en) 2017-08-31
AU2012250516A1 (en) 2013-12-19
US20200340052A1 (en) 2020-10-29
AU2020201291A1 (en) 2020-03-12
AU2017268486A1 (en) 2017-12-14
US20140335514A1 (en) 2014-11-13
KR102010601B1 (ko) 2019-08-13
US20180112263A1 (en) 2018-04-26
AU2017268486B2 (en) 2019-11-21
KR20190095531A (ko) 2019-08-14
KR102252447B1 (ko) 2021-05-17
JP7111773B2 (ja) 2022-08-02
CN103635593A (zh) 2014-03-12
US20220017957A1 (en) 2022-01-20
BR112013028296B1 (pt) 2020-03-24
KR20140044327A (ko) 2014-04-14
US10745749B2 (en) 2020-08-18
JP6404118B2 (ja) 2018-10-10
EP2705162B1 (en) 2018-07-11
JP6734887B2 (ja) 2020-08-05
KR20210056458A (ko) 2021-05-18
JP2022137291A (ja) 2022-09-21
WO2012151560A3 (en) 2013-03-21
JP2020202831A (ja) 2020-12-24
JP2018138041A (ja) 2018-09-06
US9834817B2 (en) 2017-12-05
AU2020201291B2 (en) 2023-03-09
EP2705162A4 (en) 2014-12-17
EP3382039A1 (en) 2018-10-03
JP2014513963A (ja) 2014-06-19
WO2012151560A2 (en) 2012-11-08
CN103635593B (zh) 2018-03-20
EP2705162A2 (en) 2014-03-12
EP3382039B1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
BR112013028296A2 (pt) métodos para detecção de variantes de sequências de ácido nucléico
BR112015008708A2 (pt) composição para clivagem de dna alvo compreendendo um rna guia específico para o dna alvo e ácido nucleico que codifica proteína cas ou proteína cas e uso da mesma
BR112018075479A2 (pt) portadores híbridos para carga de ácido nucleico
BR112013020773A2 (pt) "método para a detecção localizada in situ de rna, método para a determinação da presença e da localização de uma sequência genética, conjunto de sondas em cadeado, uso do conjunto de sondas, kit e método para a identificação de uma célula"
WO2012095639A3 (en) Methods, compositions, and kits for determing the presence/absence of a varian nucleic acid sequence
BR112014031365A2 (pt) métodos de detectar doenças ou condições
BR112013024423A2 (pt) detecção de doença em plantas
BR112014002614A2 (pt) anticorpo ou um fragmento do mesmo, que tem reatividade imunológica com uma proteína caprin-1, composição farmacêutica e combinação farmacêutica para tratamento e/ou prevenção de câncer, dna e método para tratamento e/ou prevenção de câncer
EA201400119A1 (ru) Фармацевтическая композиция, способы лечения и их применение
BRPI0911511B8 (pt) formulação de dna liofilizadas para aumentar a expressão de dna de plasmídeo
BR112013004440A2 (pt) método para administração parenteral de uma composição, composição farmacêutica para administração parenteral, kit e sistema farmacêutico para administração parenteral
BR112013022332A2 (pt) métodos para tratamento e/ou prevenção de hiperuricemia ou de um distúrbio metabólico associado com a hiperuricemia, e para melhorar o controle do nível de ácido úrico no sangue, e, composição farmacêutica
BR112012026724A2 (pt) combinação de fármcos com pró-fármacos ligados à proteína
BR112015002555A2 (pt) sistema para a separação de plasma e/ou soro do sangue e método para a separação de plasma e/ou do soro do sangue com um sistema de separação do plasma e/ou do soro
BR112014027283A2 (pt) variantes de enzima aprimoradas
BR112014011357A2 (pt) método de perfuração usando quebrador enzimático de manano-hidrolase
BR112013029472A2 (pt) carcaça de componente de sensor
BR112017014116A2 (pt) pcr quantitativo multiplex
BR112014010852A8 (pt) método para determinar status de perigo para aeronaves em combate
BR112015001601A2 (pt) células de levedura tendo curso de tca redutor de piruvato em succinato e superexpressão de uma enzima transidrogenase nad(p)+ exógena
BR112017024702A2 (pt) detecção de ácidos nucleicos-alvo e variantes
BR112014009223A8 (pt) método para o diagnóstico da doença de niemann-pick
BR112013003471A2 (pt) solução de testosterona, e, método para tratar deficiência de testosterona
CL2014001406A1 (es) Un metodo de deteccion homogeneo para un proceso de pcr usando fret que detecta la presencia o ausencia de un snp de haahasll-a122(at)t dentro del gen haahasll.
BR112013027408A2 (pt) marcador associado com a resistência à ferrugem em planta pertentence ao gênero saccharum e seu uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/05/2012, OBSERVADAS AS CONDICOES LEGAIS.